Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalMultiple Sclerosis
Volume22
Issue number10
Pages (from-to)1260-1263
Number of pages4
ISSN1352-4585
DOIs
Publication statusPublished - 2016

ID: 179090275